VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.
CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies. Leuk Lymphoma. 2022 01; 63(1):19-30.
View in:
PubMed
subject areas
Antigen Presentation
Dendritic Cells
Hematologic Neoplasms
Humans
Interleukin-3 Receptor alpha Subunit
Lectins, C-Type
Leukemia, Myeloid, Acute
Membrane Glycoproteins
Receptors, Immunologic
authors with profiles
MARINA KONOPLEVA
LAURA BOVER
SATTVA S NEELAPU
NAVEEN PEMMARAJU